Patent Assignment
Reel/Frame 060441/0185
Merger and Change of Name
Recorded: 2022-06-24
Pages: 3
Assignors
FRED HUTCHINSON CANCER RESEARCH CENTER
Executed: 2022-04-01
SEATTLE CANCER CARE ALLIANCE
Executed: 2022-04-01
Assignee
FRED HUTCHINSON CANCER CENTER
1100 FAIRVIEW AVENUE NORTH, SEATTLE, WASHINGTON, 98109
Covered Property
(1)
Reducing CD33 Expression to Selectively Protect Therapeutic Cells
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 6, 2021
From: HUMBERT, OLIVIER; KIEM, HANS-PETER; WALTER, ROLAND B.
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 055842/0289 →
Confirmatory License
Nov 22, 2023
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065665/0317 →